Published in Nature on November 21, 1970
The relationship between antigenic structure and the requirement for thymus-derived cells in the immune response. J Exp Med (1971) 4.03
Cell fractionation and arrangement on fibers, beads, and surfaces. Proc Natl Acad Sci U S A (1971) 2.93
Recent observations and concepts in immunological unresponsiveness and autoimmunity. Clin Exp Immunol (1971) 2.45
T and B lymphocytes in mice studied by using antisera against surface antigenic markers. Am J Pathol (1971) 1.09
Cellular mechanisms of escape from immunological tolerance. Immunology (1972) 0.94
Prior exposure to subimmunogenic amounts of some bacterial lipopolysaccharides induces specific immunological unresponsiveness. Infect Immun (1987) 0.91
The mode of interaction with macrophages of two ordered synthetic polypeptides which differ in their thymus dependency. Immunology (1978) 0.82
Immunogenicity of Bacteroides isolated from mice: relationship between immunogenicity and cell wall antigens. Infect Immun (1979) 0.75
Regulation of cytokine expression by an autoreactive B cell clone derived from MRL/MP-lpr/lpr mice. Clin Exp Immunol (1998) 0.75
STUDIES OF UREA EXCRETION. III: The Influence of Body Size on Urea Output. J Clin Invest (1928) 45.56
STUDIES OF UREA EXCRETION: VI. Comparison of the Blood Urea Clearance with Certain Other Measures of Renal Function. J Clin Invest (1930) 7.46
Mitogens as probes for immunocyte activation and cellular cooperation. Transplant Rev (1972) 5.66
Selective induction of DNA synthesis in T and B lymphocytes. Cell Immunol (1972) 4.94
Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides. Eur J Immunol (1972) 4.64
Lipopolysaccharide can substitute for helper cells in the antibody response in vitro. Eur J Immunol (1972) 2.58
Studies on antigen-binding cells. I. The origin of reactive cells. Cell Immunol (1970) 2.53
Transplantation of porcine fetal pancreas to diabetic patients. Lancet (1994) 2.52
Activation of B lymphocytes by locally concentrated concanavalin A. Eur J Immunol (1972) 2.41
"Spontaneous" B cell activation due to loss of normal mouse serum suppressor. Eur J Immunol (1972) 2.38
A rapid method for the separation of functional lymphoid cell populations of human and animal origin on PVP-silica (Percoll) density gradients. Scand J Immunol (1979) 2.35
Long term growth in vitro of human T cell blasts with maintenance of specificity and function. J Immunol (1979) 2.25
Phase-coupling of theta-gamma EEG rhythms during short-term memory processing. Int J Psychophysiol (2002) 2.09
Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting. Circulation (2005) 1.83
Polyclonal antibody secretion in human lymphocytes induced by killed staphylococcal bacteria and by lipopolysaccharide. Scand J Immunol (1977) 1.82
B lymphocytes can be stimulated by concanavalin A in the presence of humoral factors released by T cells. Eur J Immunol (1972) 1.81
Development of allergies and asthma in infants and young children with atopic dermatitis--a prospective follow-up to 7 years of age. Allergy (2000) 1.75
Reconstitution of the antibody response in vitro of T cell-deprived spleen cells by supernatants from spleen cell cultures. J Immunol (1972) 1.73
Effect of antigenic competition on antigen-sensitive cells and on adoptively transferred immunocompetent cells. Cell Immunol (1970) 1.71
Xylene-free method for histological preparation: a multicentre evaluation. Lab Invest (2001) 1.70
Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J Immunol Methods (1993) 1.60
HLA and rheumatoid arthritis. A study of five families. Tissue Antigens (1981) 1.58
HL-A antigens in sarcoidosis. Tissue Antigens (1973) 1.55
Plaque-formation by non-immune and x-irradiated lymphoid cells on monolayers of mouse embryo cells. Nature (1965) 1.55
Requirement for adherent cells in the primary and secondary immune response in vitro. Eur J Immunol (1972) 1.51
Lipopolysaccharides can convert heterologous red cells into thymus-independent antigens. Cell Immunol (1972) 1.48
Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen. J Exp Med (1976) 1.48
Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol (1993) 1.48
Role of polyclonal activation in specific immune responses. Relevance for findings of antibody activity in various diseases. Scand J Immunol (1980) 1.46
Rapid breaking of tolerance against Escherichia coli lipopolysaccharide in vivo and in vitro. J Exp Med (1972) 1.40
Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci U S A (1989) 1.36
In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. Clin Exp Immunol (1970) 1.32
Scandiatransplant: preliminary report of a kidney exchange program. Transplant Proc (1971) 1.32
Studies on antigen-binding cells. II. Relationship to antigen-sensitive cells. Cell Immunol (1970) 1.31
B-cell mitogenic effects on human lymphocytes of rabbit anti-human beta 2-microglobulin. Scand J Immunol (1975) 1.27
Effect of allogeneic cell interaction on the primary immune response in vitro. Cell types involved in suppression and stimulation of antibody synthesis. Clin Exp Immunol (1972) 1.27
Mitogen-induced lymphocyte-mediated cytotoxicity in vitro: effect of mitogens selectively activating T or B cells. Eur J Immunol (1972) 1.26
The role of adherent cells in B and T lymphocyte activation. Immunol Rev (1978) 1.23
Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion (1998) 1.21
Antigenic competition in vitro between heterologous erythrocytes. Eur J Immunol (1972) 1.20
HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology. Hum Immunol (1987) 1.20
Complete heart block--another HLA B27 associated disease manifestation. Tissue Antigens (1983) 1.16
CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J Virol (1993) 1.14
B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia. Clin Exp Immunol (1978) 1.14
Cytotoxicity by nonimmune allogeneic lymphoid cells. Specific suppression by antibody treatment of the lymphoid cells. J Exp Med (1967) 1.12
Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J Immunol (1986) 1.11
Induction of antibody synthesis in human B lymphocytes by different polyclonal B cell activators: evaluation by direct and indirect PFC assays. Immunol Rev (1979) 1.10
Antigenic competition in vitro of spleen cells subjected to a graft-versus-host reaction. Immunology (1971) 1.09
Synovial fluid cytokines in patients with rheumatoid arthritis or other arthritic lesions. Scand J Immunol (1998) 1.08
Reconstitution of immunocompetence in B cells by addition of concanavalin A or concanavalin A-treated thymus cells. Clin Exp Immunol (1973) 1.08
A prospective 12-year follow-up study of children with wheezy bronchitis. Acta Paediatr Scand (1984) 1.07
The alpha chain, not the beta chain of HLA-DR antigens participates in activation of T cells in autologous mixed lymphocyte reaction. Immunogenetics (1982) 1.07
B cell differentiation factor in synovial fluid of patients with rheumatoid arthritis. Immunol Rev (1984) 1.07
HLA phenotypes and diabetic retinopathy. Diabetologia (1978) 1.06
Reversibility of high dose unresponsiveness to concanavalin A in thymus lymphocytes. Immunology (1972) 1.04
Antigen-binding cells in mice immune or tolerant to Escherichia coli polysaccharide. J Exp Med (1971) 1.04
HLA haplotypes in families with high frequency of multiple sclerosis. Arch Neurol (1976) 1.04
Effects of some immunosuppressive procedures on myasthenia gravis. Ann N Y Acad Sci (1976) 1.04
Optimal conditions for polyclonal antibody secretion and DNA synthesis in human blood and spleen lymphocytes by lipopolysaccharide. Scand J Immunol (1978) 1.04
Antibody production and DNA synthesis of human lymphocyte subpopulations induced by PPD tuberculin. Clin Exp Immunol (1979) 1.03
The use of bacteria for the functional characterization of human lymphocyte subpopulations in various lymphoid organs. Scand J Immunol (1978) 1.03
HLA-A,B,C and DR antigens in psoriasis. Tissue Antigens (1981) 1.00
Neutropenia and insufficiency of the exocrine pancreas. Acta Paediatr Scand (1967) 1.00
Residual C-peptide excretion is associated with a better long-term glycemic control and slower progress of retinopathy in type I (insulin-dependent) diabetes mellitus. J Diabet Complications (1991) 1.00
HLA-DR beta genes vary in number between different DR specificities, whereas the number of DQ beta genes is constant. J Immunol (1985) 0.99
Mitogen-induced differentiation of human CLL lymphocytes to antibody-secreting cells. Scand J Immunol (1979) 0.99
Unilateral, isometric bite force in 8-68-year-old women and men related to occlusal factors. Scand J Dent Res (1990) 0.99
Quantitation of the number of mitogen molecules activating DNA synthesis in T and B lymphocytes. Clin Exp Immunol (1973) 0.98
Genomic hybridization with class II transplantation antigen cDNA probes as a complementary technique in tissue typing. Hum Immunol (1984) 0.97
Antigenic markers on mouse lymphoid cells: the presence of MBLA on antibody forming cells and antigen binding cells. Cell Immunol (1972) 0.96
The concept of immunological surveillance against neoplasia. Transplant Rev (1976) 0.96
Cytotoxic effects in vitro by lymphoid cells from specifically tolerant animals. Immunology (1969) 0.96
HLA--determination in families with hereditary ataxia. Tissue Antigens (1978) 0.95
Tuberculous meningitis: immune reactions within the central nervous system. Scand J Immunol (1981) 0.95
Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB x NZW)F1 hybrids. Eur J Immunol (1996) 0.94
HLA-A, -B, -C and -D antigens in male patients with myasthenia gravis. Tissue Antigens (1978) 0.94
Cyclosporin A treatment in a case of relapsing polychondritis. Scand J Rheumatol (1984) 0.94
Hapten-induced paralysis. I. Evidence for the persistence of hapten-specific immunocompetent B lymphocytes in specifically paralyzed mice. Eur J Immunol (1974) 0.93
Genetic basis of multiple sclerosis: HLA antigens, disease progression, and oligoclonal IgG in CSF. Acta Neurol Scand (1979) 0.92
Sensitization to airborne and food allergens in Reykjavík (Iceland) and Uppsala (Sweden) - a comparative study. Allergy (1999) 0.92
High incidence of spontaneous Ig-producing lymphocytes in peripheral blood and synovial fluid of patients with active seropositive rheumatoid arthritis. Scand J Immunol (1982) 0.92
Neutralization of human cytomegalovirus by human CD13-specific antibodies. J Infect Dis (1996) 0.91
Xenograft rejection of porcine islet-like cell clusters in normal and natural killer cell-depleted mice. Transplantation (1996) 0.91
Characterization of human adenoid cells using surface and functional markers for lymphocyte subpopulations. Clin Exp Immunol (1977) 0.91
Studies on the major histocompatibility system in patients with ankylosing spondylitis. Tissue Antigens (1975) 0.90
Markedly elevated serum IgE levels following allogeneic and syngeneic bone marrow transplantation. Blood (1983) 0.90
Identification of five lymphocyte activating determinants in man. Tissue Antigens (1975) 0.90
Myasthenia gravis: studies on HL-A antigens and lymphocyte subpopulations in patients with myasthenia gravis. Clin Exp Immunol (1975) 0.90
Adjuvants influence the immunoglobin subclass distribution of immune responses in vivo. Scand J Immunol (1984) 0.89
HLA antigens in selective IgA deficiency: distribution in healthy donors and patients with recurrent respiratory tract infections. Tissue Antigens (1984) 0.89
Considerations of some current concepts in cancer research. J Natl Cancer Inst (1975) 0.89
A simple immunoenzyme batch staining method for the enumeration of peripheral human T lymphocyte subsets. J Immunol Methods (1983) 0.89
Enumeration of IgA producing cells by the enzyme linked immunospot (ELISPOT) technique to evaluate sulphasalazine effects in inflammatory arthritides. Ann Rheum Dis (1991) 0.88
Patients with psoriasis often have increased serum levels of IgA antibodies to gliadin. Br J Dermatol (1993) 0.88
Prevalence of sensitization to food allergens in adult Swedes. Ann Allergy Asthma Immunol (1996) 0.87
Antigen-binding cells in immune and tolerant animals. Transplant Rev (1972) 0.87
Antigenic markers on mouse lymphoid cells: origin of cells mediating immunologic memory. Cell Immunol (1973) 0.87
Long-term maintenance of HLA-D restricted T cells specific for soluble antigens. Scand J Immunol (1980) 0.87
A DR4-associated DR-DQ haplotype is significantly associated with rheumatoid arthritis. Arthritis Rheum (1988) 0.87